Inactive Trojan Bacteria as Safe Drug Delivery Vehicles Crossing the Blood-Brain Barrier.

Escherichia coli K1 (EC-K1) can bypass the blood-brain barrier (BBB) and cause meningitis. Excitingly, we find the "dead EC-K1" can safely penetrate the BBB because they retain the intact structure and chemotaxis of the live EC-K1, while losing their pathogenicity. Based on this, we develop a safe "dead EC-K1"-based drug delivery system, in which EC-K1 engulf the maltodextrin (MD)-modified therapeutics through the bacteria-specific MD transporter pathway, followed by the inactivation via UV irradiation. We demonstrate that the dead bacteria could carry therapeutics (e.g., indocyanine green (ICG)) and together bypass the BBB after intravenous injection into the mice, delivering ∼3.0-fold higher doses into the brain than free ICG under the same conditions. What is more, all mice remain healthy even after 14 days of intravenous injection of ∼109 CFU of inactive bacteria. As a proof of concept, we demonstrate the developed strategy enables the therapy of bacterial meningitis and glioblastoma in mice.

[1]  Yuxin Zhang,et al.  Improved Tumor Infiltration and Immunomodulation for Tumor Therapy: A Pathway Based on Tetrahedral Framework Nucleic Acids Coupled Bacterial Nanocells. , 2022, Nano letters.

[2]  R. Weichselbaum,et al.  Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration , 2022, Nature nanotechnology.

[3]  Qi-wen Chen,et al.  Probiotic Spore-Based Oral Drug Delivery System for Enhancing Pancreatic Cancer Chemotherapy by Gut-Pancreas-Axis-Guided Delivery. , 2022, Nano letters.

[4]  Bin Song,et al.  Bacteria loaded with glucose polymer and photosensitive ICG silicon-nanoparticles for glioblastoma photothermal immunotherapy , 2022, Nature Communications.

[5]  Xuan Yi,et al.  Pleiotropic Immunomodulatory Functions of Radioactive Inactivated Bacterial Vectors for Enhanced Cancer Radio-immunotherapy. , 2022, ACS nano.

[6]  Bin Song,et al.  Trojan Nanobacteria System for Photothermal Programmable Destruction of Deep Tumor Tissues. , 2022, Angewandte Chemie.

[7]  Liang Han,et al.  Biomimetic Lipopolysaccharide‐Free Bacterial Outer Membrane‐Functionalized Nanoparticles for Brain‐Targeted Drug Delivery , 2022, Advanced science.

[8]  Tal Danino,et al.  A programmable encapsulation system improves delivery of therapeutic bacteria in mice , 2022, Nature Biotechnology.

[9]  Bin Song,et al.  Bacteria eat nanoprobes for aggregation-enhanced imaging and killing diverse microorganisms , 2022, Nature Communications.

[10]  Jianping Zhou,et al.  Lipoprotein-Inspired Nanoscavenger for the Three-Pronged Modulation of Microglia-Derived Neuroinflammation in Alzheimer's Disease Therapy. , 2022, Nano letters.

[11]  Jinhui Wu,et al.  Systemic immune responses to irradiated tumours via the transport of antigens to the tumour periphery by injected flagellate bacteria , 2022, Nature Biomedical Engineering.

[12]  Jinyao Liu,et al.  Spatiotemporally Controllable Distribution of Combination Therapeutics in Solid Tumors by Dually Modified Bacteria , 2021, Advanced materials.

[13]  M. Wan,et al.  Cascade‐Amplifying Synergistic Therapy for Intracranial Glioma via Endogenous Reactive Oxygen Species‐Triggered “All‐in‐One” Nanoplatform , 2021, Advanced Functional Materials.

[14]  R. Liu,et al.  Aptamer-assisted tumor localization of bacteria for enhanced biotherapy , 2021, Nature Communications.

[15]  J. Guan,et al.  A Nanoantidote Alleviates Glioblastoma Chemotoxicity without Efficacy Compromise. , 2021, Nano letters.

[16]  P. Decuzzi,et al.  Conformable hierarchically engineered polymeric micromeshes enabling combinatorial therapies in brain tumours , 2021, Nature Nanotechnology.

[17]  G. Terstappen,et al.  Strategies for delivering therapeutics across the blood–brain barrier , 2021, Nature Reviews Drug Discovery.

[18]  I. Obeso,et al.  Blood-brain barrier opening with focused ultrasound in Parkinson’s disease dementia , 2021, Nature Communications.

[19]  Y. Liu,et al.  Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection , 2021, Nature Nanotechnology.

[20]  Zhichao Feng,et al.  "Trojan Horse" Salmonella Enabling Tumor Homing of Silver Nanoparticles via Neutrophil Infiltration for Synergistic Tumor Therapy and Enhanced Biosafety. , 2020, Nano letters.

[21]  Si-Xue Cheng,et al.  Intervening Tumor Progression by Coupling Bacteria Respiration with Tumor Metabolism. , 2020, Angewandte Chemie.

[22]  Kai Yang,et al.  Bacteria-triggered tumor-specific thrombosis to enable potent photothermal immunotherapy of cancer , 2020, Science Advances.

[23]  I. Steinberg,et al.  Maltotriose-based probes for fluorescence and photoacoustic imaging of bacterial infections , 2020, Nature Communications.

[24]  O. Farokhzad,et al.  Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy. , 2020, Nano letters.

[25]  I. Csóka,et al.  Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook. , 2020, Drug discovery today.

[26]  Guojun Huang,et al.  Bioengineering Bacterial Vesicle-Coated Polymeric Nanomedicine for Enhanced Cancer Immunotherapy and Metastasis Prevention. , 2019, Nano letters.

[27]  Yu Chen,et al.  Photosynthetic Tumor Oxygenation by Photosensitized Cyanobacterial Cells for Enhanced Photodynamic Therapy. , 2019, Angewandte Chemie.

[28]  Yining Zhu,et al.  Combination of Bacterial‐Photothermal Therapy with an Anti‐PD‐1 Peptide Depot for Enhanced Immunity against Advanced Cancer , 2019, Advanced Functional Materials.

[29]  Lin-Ping Wu,et al.  Crossing the blood-brain-barrier with nanoligand drug carriers self-assembled from a phage display peptide , 2019, Nature Communications.

[30]  Yuanyuan Su,et al.  Multifunctional nanoagents for ultrasensitive imaging and photoactive killing of Gram-negative and Gram-positive bacteria , 2019, Nature Communications.

[31]  A. Krainer,et al.  Antisense Oligonucleotide Therapies for Neurodegenerative Diseases. , 2019, Annual review of neuroscience.

[32]  P. Wen,et al.  Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma , 2018, Nature Medicine.

[33]  Shibin Zhou,et al.  Tumour-targeting bacteria engineered to fight cancer , 2018, Nature Reviews Cancer.

[34]  S. Antimisiaris,et al.  Nose‐to‐brain drug delivery: An update on clinical challenges and progress towards approval of anti‐Alzheimer drugs , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[35]  Zi-Hao Li,et al.  Bacteria-Mediated Tumor Therapy Utilizing Photothermally-Controlled TNF-α Expression via Oral Administration. , 2018, Nano letters.

[36]  Ran Mo,et al.  Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence. , 2017, Nature nanotechnology.

[37]  Xiangjun Zhang,et al.  Yeast Microcapsule-Mediated Targeted Delivery of Diverse Nanoparticles for Imaging and Therapy via the Oral Route. , 2017, Nano letters.

[38]  S. Bourdoulous,et al.  A journey into the brain: insight into how bacterial pathogens cross blood–brain barriers , 2017, Nature Reviews Microbiology.

[39]  W. Banks,et al.  From blood–brain barrier to blood–brain interface: new opportunities for CNS drug delivery , 2016, Nature Reviews Drug Discovery.

[40]  Yuan Ping,et al.  Engineering nanoparticle-coated bacteria as oral DNA vaccines for cancer immunotherapy. , 2015, Nano letters.

[41]  D. Weiss,et al.  PET imaging of bacterial infections with fluorine-18-labeled maltohexaose. , 2014, Angewandte Chemie.

[42]  Takahiro Nomoto,et al.  Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier. , 2013, ACS nano.

[43]  N. Prasadarao,et al.  gp96 expression in neutrophils is critical for the onset of Escherichia coli K1 (RS218) meningitis , 2011, Nature communications.

[44]  N. Forbes.  Engineering the perfect (bacterial) cancer therapy , 2010, Nature Reviews Cancer.

[45]  M. Grote,et al.  The maltose ATP‐binding cassette transporter in the 21st century – towards a structural dynamic perspective on its mode of action , 2010, Molecular microbiology.

[46]  W. Goebel,et al.  Maltose and Maltodextrin Utilization by Listeria monocytogenes Depend on an Inducible ABC Transporter which Is Repressed by Glucose , 2010, PloS one.

[47]  N. Prasadarao,et al.  Nitric oxide/cGMP signalling induces Escherichia coli K1 receptor expression and modulates the permeability in human brain endothelial cell monolayers during invasion , 2010, Cellular microbiology.

[48]  K. Kim.  Mechanisms of microbial traversal of the blood–brain barrier , 2008, Nature Reviews Microbiology.

[49]  B. Beutler,et al.  Innate immune sensing and its roots: the story of endotoxin , 2003, Nature Reviews Immunology.

[50]  K. Kinzler,et al.  Combination bacteriolytic therapy for the treatment of experimental tumors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Samuel I. Miller,et al.  Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo , 1999, Nature Biotechnology.